Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Merck
Cerilliant
Julphar
Express Scripts
UBS
QuintilesIMS
US Army
Baxter

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084444

« Back to Dashboard

NDA 084444 describes PHENAPHEN W/ CODEINE NO. 2, which is a drug marketed by Robins Ah and is included in one NDA. Additional details are available on the PHENAPHEN W/ CODEINE NO. 2 profile page.

The generic ingredient in PHENAPHEN W/ CODEINE NO. 2 is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.
Summary for 084444
Tradename:PHENAPHEN W/ CODEINE NO. 2
Applicant:Robins Ah
Ingredient:acetaminophen; codeine phosphate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength325MG;15MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Cipla
Johnson and Johnson
Julphar
Cerilliant
Farmers Insurance
Accenture
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.